251.82
2.68 (1.08%)
2.68 (1.08%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 1,230,934 |
|
|||||
News | - | ||||||
Day High | 253.38 | Low High |
|||||
Day Low | 248.13 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Becton Dickinson and Company | BDX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
249.29 | 248.13 | 253.38 | 251.82 | 249.14 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
25,271 | 1,230,934 | $ 251.68 | $ 309,802,454 | - | 215.90 - 280.62 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 115,188 | $ 251.82 | USD |
Becton Dickinson and Company Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 71.58B | 284.27M | 283.92M | $ 19.41B | $ 1.59B | 5.89 | 41.90 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ 3.48 | 1.46% | 03/09/23 | 191.81k | 0.50% |
Becton Dickinson News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 255.11 | 255.11 | 242.72 | 248.89 | 957,355 | -3.29 | -1.29% |
1 Month | 255.81 | 262.66 | 242.72 | 253.93 | 1,075,418 | -3.99 | -1.56% |
3 Months | 224.07 | 262.66 | 217.70 | 241.87 | 1,378,356 | 27.75 | 12.38% |
6 Months | 243.54 | 269.06 | 215.90 | 241.45 | 1,230,906 | 8.28 | 3.4% |
1 Year | 254.37 | 280.62 | 215.90 | 249.23 | 1,209,802 | -2.55 | -1.0% |
3 Years | 274.00 | 286.72 | 197.75 | 246.53 | 1,470,991 | -22.18 | -8.09% |
5 Years | 246.30 | 286.72 | 197.75 | 244.99 | 1,324,021 | 5.52 | 2.24% |
Becton Dickinson Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 24% of revenue. International revenue accounts for 43% of the company's business. |